Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Healthtrust
Accenture
McKinsey
Baxter
Cantor Fitzgerald
Fuji
Mallinckrodt
Chubb
Federal Trade Commission

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020576

« Back to Dashboard

NDA 020576 describes CYSTADANE, which is a drug marketed by Orphan Europe and is included in one NDA. It is available from two suppliers. Additional details are available on the CYSTADANE profile page.

The generic ingredient in CYSTADANE is betaine hydrochloride. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the betaine hydrochloride profile page.
Summary for 020576
Tradename:CYSTADANE
Applicant:Orphan Europe
Ingredient:betaine hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020576
Mechanism of ActionMethylating Activity
Medical Subject Heading (MeSH) Categories for 020576
Suppliers and Packaging for NDA: 020576
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CYSTADANE betaine hydrochloride FOR SOLUTION;ORAL 020576 NDA Orphan Europe SARL 52276-400 52276-400-01 180 g in 1 BOTTLE (52276-400-01)
CYSTADANE betaine hydrochloride FOR SOLUTION;ORAL 020576 NDA Rare Disease Therapeutics, Inc. 66621-4000 66621-4000-1 180 POWDER, FOR SOLUTION in 1 BOTTLE (66621-4000-1)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FOR SOLUTION;ORALStrength1GM/SCOOPFUL
Approval Date:Oct 25, 1996TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Fuji
Medtronic
Baxter
Federal Trade Commission
Chinese Patent Office
McKinsey
Novartis
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot